Key facts
- Augment Therapy’s last known valuation is $16.7M (Apr 2023).
- It has raised $5.9M across 2 recorded rounds; the latest was Seed Round ($500K) in Feb 2025.
- Notable investors include Plug and Play Tech Center, MassChallenge, GrowthX Capital, Matter (Consulting Services (B2B)), Jumpstart Ventures — 18 tracked in total.
- Augment Therapy has filed 2 Form Ds with the SEC since 2023, most recently Feb 2025 ($500K sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Augment Therapy
Funding rounds
2 roundsAbout Augment Therapy
Developer of an augmented reality rehabilitation exercises platform designed for enhanced therapy outcomes and fun wellness games to encourage movement at home. The company's platform uses depth-sensing camera technology that includes a library of evidence-based exercises and an interactive gamified version, enabling healthcare providers to prescribe and monitor exercises, making therapy engaging and effective for patients of all ages and abilities.
- Sector
- Healthcare
- HQ
- Chagrin Falls, OH, United States
- Founded
- 2017
- Employees
- 9
- Website
- augmenttherapy.com/
- Ownership
- Privately Held (backing)
Augment Therapy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Augment Therapy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Augment Therapy in its N-PORT filings yet. We sweep new filings monthly.